Compounds > 2',2'-difluorodeoxycytidine 5'-triphosphate
Page last updated: 2024-09-03

2',2'-difluorodeoxycytidine 5'-triphosphate and Acute Lymphoid Leukemia

2',2'-difluorodeoxycytidine 5'-triphosphate has been researched along with Acute Lymphoid Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chubb, S; Grindey, GB; Heinemann, V; Hertel, LW; Plunkett, W; Sen, A; Xu, YZ1

Other Studies

1 other study(ies) available for 2',2'-difluorodeoxycytidine 5'-triphosphate and Acute Lymphoid Leukemia

ArticleYear
Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiation.
    Cancer research, 1992, Feb-01, Volume: 52, Issue:3

    Topics: Antimetabolites, Antineoplastic; Cell Line; Cytidine Triphosphate; DCMP Deaminase; Deoxycytidine; Deoxyribonucleotides; Gemcitabine; Humans; Kinetics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribonucleotides

1992